Crocs, Inc. vs Enveric Biosciences Inc — how do they compare? Crocs, Inc. trades at $131.17 (market cap $6.48B), while Enveric Biosciences Inc trades at $1.25 (market cap $5.36M). The key difference: Crocs, Inc. is far larger — about 1209× Enveric Biosciences Inc's market cap, and Crocs, Inc. is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| CROX | ENVB | |
|---|---|---|
Market Cap | $6.48B | $5.36M |
Sector | Consumer Staples | Health |
52-Week High | $132.78 | $17.40 |
52-Week Low | $73.39 | $1.28 |
Enterprise Value | $8.08B | $449.11K |
Trailing returns across standard periods
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →